597 related articles for article (PubMed ID: 16970637)
1. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome predicts incident congestive heart failure: a 20-year follow-up study of elderly Finns.
Wang J; Sarnola K; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Atherosclerosis; 2010 May; 210(1):237-42. PubMed ID: 19945701
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
Ramezankhani A; Azizi F; Hadaegh F
Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
Meis SB; Schuster D; Gaillard T; Osei K
Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome across Europe: different clusters of risk factors.
Scuteri A; Laurent S; Cucca F; Cockcroft J; Cunha PG; Mañas LR; Mattace Raso FU; Muiesan ML; Ryliškytė L; Rietzschel E; Strait J; Vlachopoulos C; Völzke H; Lakatta EG; Nilsson PM;
Eur J Prev Cardiol; 2015 Apr; 22(4):486-91. PubMed ID: 24647805
[TBL] [Abstract][Full Text] [Related]
6. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
[TBL] [Abstract][Full Text] [Related]
8. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score.
Gurka MJ; Lilly CL; Oliver MN; DeBoer MD
Metabolism; 2014 Feb; 63(2):218-25. PubMed ID: 24290837
[TBL] [Abstract][Full Text] [Related]
9. Prognostic interactions between cardiovascular risk factors.
Vishram JK
Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
[TBL] [Abstract][Full Text] [Related]
10. Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey.
Li W; Song F; Wang X; Wang D; Chen D; Yue W; Zhang H; Wang Z; Lu Z
BMJ Open; 2019 Aug; 9(8):e027545. PubMed ID: 31427317
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome components and diabetes incidence according to the presence or absence of impaired fasting glucose: The Japan Epidemiology Collaboration on Occupational Health Study.
Kurotani K; Miyamoto T; Kochi T; Eguchi M; Imai T; Nishihara A; Tomita K; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Nagahama S; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Sasaki N; Hori A; Nishiura C; Kuwahara K; Kuroda R; Akter S; Kashino I; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
J Epidemiol; 2017 Sep; 27(9):408-412. PubMed ID: 28434837
[TBL] [Abstract][Full Text] [Related]
12. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
[TBL] [Abstract][Full Text] [Related]
13. A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria.
Hwang IC; Kim KK; Jee SH; Kang HC
Yonsei Med J; 2011 Mar; 52(2):220-6. PubMed ID: 21319338
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study.
Mozaffarian D; Kamineni A; Prineas RJ; Siscovick DS
Arch Intern Med; 2008 May; 168(9):969-78. PubMed ID: 18474761
[TBL] [Abstract][Full Text] [Related]
15. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome.
Gaillard T; Schuster D; Osei K
Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
18. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease.
Kanaya AM; Herrington D; Vittinghoff E; Lin F; Bittner V; Cauley JA; Hulley S; Barrett-Connor E
Ann Intern Med; 2005 May; 142(10):813-20. PubMed ID: 15897531
[TBL] [Abstract][Full Text] [Related]
19. Incidence of cardiovascular disease in older Americans: the cardiovascular health study.
Arnold AM; Psaty BM; Kuller LH; Burke GL; Manolio TA; Fried LP; Robbins JA; Kronmal RA
J Am Geriatr Soc; 2005 Feb; 53(2):211-8. PubMed ID: 15673343
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
